AEIS vs RTX

AEIS demonstrates mixed financial health with a Piotroski F-Score of 4/9 indicating a stable but not strong foundation, while the absence of an Altman Z-Score raises caution regarding default risk. Despite this, the stock trades at a premium valuation (P/E 78.04 vs. sector avg 73.84), yet exhibits robust revenue growth (17.8% YoY) and strong earnings surprise history (average +14.01% over last 4 quarters). The intrinsic value estimate of $32.90 is significantly below the current price of $302.02, suggesting high growth expectations are priced in. Insider selling activity over the past six months (9 transactions, $6.62M in sales) introduces bearish sentiment, though the company maintains solid profitability and a manageable debt/equity ratio of 0.50. Price trades at a 818.0% premium to fair value estimate ($32.90), limiting near-term upside from a valuation perspective.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.